The invention relates to peptides and pharmaceutical compositions comprising peptides that find use in the prevention or treatment of cancer, in particular breast cancer and colorectal cancer. The invention also relates to methods of inducing a cytotoxic T cell response in a subject or treating cancer by administering pharmaceutical compositions comprising the peptides, and companion diagnostic methods of identifying subjects for treatment. The peptides comprise T cell epitopes that are immunogenic in a high percentage of patients.